awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36821702-C62C50A9-6D93-4C51-8DAF-3F82E8A59AC4
Q36821702-C62C50A9-6D93-4C51-8DAF-3F82E8A59AC4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36821702-C62C50A9-6D93-4C51-8DAF-3F82E8A59AC4
A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer.
P2860
Q36821702-C62C50A9-6D93-4C51-8DAF-3F82E8A59AC4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36821702-C62C50A9-6D93-4C51-8DAF-3F82E8A59AC4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d8e339365937b85e4e31da53200342448517285c
P2860
The heat shock protein 90 inhibitor IPI-504 induces apoptosis of AKT-dependent diffuse large B-cell lymphomas.